NCT04901312

Brief Summary

The United States is experiencing an opioid epidemic. Sadly, opioid-related fatalities are on the rise, causing profound emotional, financial, and cultural impacts. One way to reduce these negative impacts is to prevent people from developing opioid use problems in the first place. Research shows that youth and young adults in the juvenile justice system have higher rates of opioid use disorder than other young people in the general population. The POST Study seeks develop, implement and evaluate the effectiveness and cost of 2 opioid use prevention programs of varying intensities. The prevention programs are designed specifically for youth and young adults living in justice settings. It is implemented during the time they are transitioning out of incarceration and back into the community. The research team hopes their results will help justice settings implement their own effective opioid prevention programs in the future.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
215

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Jan 2021

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 20, 2021

Completed
22 days until next milestone

First Submitted

Initial submission to the registry

February 11, 2021

Completed
3 months until next milestone

First Posted

Study publicly available on registry

May 25, 2021

Completed
3.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 31, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

August 31, 2024

Completed
Last Updated

October 27, 2022

Status Verified

October 1, 2022

Enrollment Period

3.6 years

First QC Date

February 11, 2021

Last Update Submit

October 24, 2022

Conditions

Keywords

Juvenile RehabilitationAdolescentYoung AdultJuvenile JusticeOpioidsOpioid Use DisorderSubstance UsePreventionRecidivismSubstance Use DisorderCost EffectivenessBenefit Cost Analysis

Outcome Measures

Primary Outcomes (8)

  • Number of substance use episodes

    Self-reported number of episodes of substance use on days any substance was used in the past 30 days based on questions developed in collaboration with coordinating center Research Triangle Institute and other grantees.

    Last 30 days at 2 months post-release (Phase I)

  • Number of substance use episodes

    Self-reported number of episodes of substance use on days any substance was used in the past 30 days based on questions developed in collaboration with coordinating center Research Triangle Institute and other grantees.

    Last 30 days at 3 months post-release (Phase II)

  • Number of substance use episodes

    Self-reported number of episodes of substance use on days any substance was used in the past 30 days based on questions developed in collaboration with coordinating center Research Triangle Institute and other grantees.

    Last 30 days at 6 months post-release (Phase II)

  • Frequency of substance use episodes

    Self-reported number of days of any substance use in the past 30 days based on questions developed in collaboration with coordinating center Research Triangle Institute and other grantees.

    Last 30 days at 2 months post-release (Phase I)

  • Frequency of substance use episodes

    Self-reported number of days of any substance use in the past 30 days based on questions developed in collaboration with coordinating center Research Triangle Institute and other grantees.

    Last 30 days at 3 months post-release (Phase II)

  • Frequency of substance use episodes

    Self-reported number of days of any substance use in the past 30 days based on questions developed in collaboration with coordinating center Research Triangle Institute and other grantees.

    Last 30 days at 6 months post-release (Phase II)

  • Rate of Recidivism

    Convictions in either the juvenile or adult justice system for offenses within an 18-month period

    12 months post-release

  • Rate of Recidivism

    Convictions in either the juvenile or adult justice system for offenses within an 18-month period

    18 months post-release

Secondary Outcomes (17)

  • Number of new opioid users

    6 months post-release (Phase II)

  • Number of participants with escalated opioid use

    Last 30 days at 2 months post-release vs. before incarceration (Phase I)

  • Number of participants with escalated opioid use

    Last 30 days at 3 months post-release vs. before incarceration (Phase II)

  • Number of participants with escalated opioid use

    Last 30 days at 6 months post-release vs. at 3 months post-release (Phase II)

  • Number of use episodes of specific substances (e.g. opioids, marijuana, etc.)

    Last 30 days at 2 months post-release (Phase I)

  • +12 more secondary outcomes

Other Outcomes (4)

  • Participant attendance

    2 months post-release (Phase I)

  • Participant attendance

    3 months post-release (Phase II)

  • Participant satisfaction

    2 months post-release (Phase I)

  • +1 more other outcomes

Study Arms (2)

Enhanced A-CRA (E-ACRA)

EXPERIMENTAL

Higher intensity

Behavioral: Adolescent Community Reinforcement ApproachBehavioral: Assertive Continuing CareBehavioral: Trauma Affect Regulation Guide for Education and TherapyBehavioral: Motivational InterviewingOther: Opioid Education Workbook

Assertive Community Support (ACS)

EXPERIMENTAL

Lower intensity

Behavioral: Adolescent Community Reinforcement ApproachBehavioral: Assertive Continuing CareBehavioral: Motivational InterviewingOther: Opioid Education Workbook

Interventions

The Adolescent Community Reinforcement Approach (A-CRA) is a developmentally-appropriate behavioral treatment for youth and young adults ages 12 to 24 years old with substance use disorders. A-CRA seeks to increase the family, social, and educational/vocational reinforces to support recovery. This intervention has been implemented in outpatient, intensive outpatient, and residential treatment settings. A-CRA includes guidelines for three types of sessions: individuals alone, parents/caregivers alone, and individuals and parents/caregivers together. According to the individual's needs and self-assessment of happiness in multiple life areas, clinicians choose from a variety of A-CRA procedures that address, for example, problem-solving skills to cope with day-to-day stressors, communication skills, and active participation in positive social and recreational activities with the goal of improving life satisfaction and eliminating alcohol and substance use problems.

Also known as: A-CRA, ACRA
Assertive Community Support (ACS)Enhanced A-CRA (E-ACRA)

Assertive Continuing Care (ACC) uses Community Reinforcement Approach (CRA) procedures, home visits, and case management for individuals following an initial substance use treatment episode. It stresses rapid initiation of services after discharge from residential, intensive outpatient, or regular outpatient treatment in order to promote recovery and prevent relapse.

Also known as: ACC
Assertive Community Support (ACS)Enhanced A-CRA (E-ACRA)

Trauma Affect Regulation: Guide for Education and Therapy is a psychosocial intervention for traumatized adolescents, adults, and families, and for workforce and organizational responses to secondary/vicarious traumatization. T4, the 4-session version, provides education about the impact of complex traumatic stress on the brain's stress response system, and strengths-based practical skills for re-setting the trauma-related alarm/survival reactions that occur in complex PTSD.

Also known as: T4, TARGET
Enhanced A-CRA (E-ACRA)

Motivational interviewing is a collaborative, person-centered form of guiding to elicit and strengthen motivation for change.

Also known as: MI
Assertive Community Support (ACS)Enhanced A-CRA (E-ACRA)

A digital workbook designed to be completed on a computer in about 2 hours. Topics include opioid use, opioid use disorder, and prevention and treatment of opioid overdose.

Also known as: Education
Assertive Community Support (ACS)Enhanced A-CRA (E-ACRA)

Eligibility Criteria

Age15 Years - 25 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64)

You may qualify if:

  • Age 15-25
  • Leaving a Washington State detention facility or group home in the next 5-7 months
  • Able to speak/understand English sufficiently to participate meaningfully in the intervention and assessments

You may not qualify if:

  • Diagnosed with a moderate or severe Opioid Use Disorder
  • Has a learning or mental health issue severe enough that they are unable to participate meaningfully in the intervention and assessments (e.g. schizophrenia or severe developmental disability)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Washington State Department of Children, Youth and Families

Olympia, Washington, 98504, United States

RECRUITING

Related Publications (57)

  • Martins SS, Segura LE, Santaella-Tenorio J, Perlmutter A, Fenton MC, Cerda M, Keyes KM, Ghandour LA, Storr CL, Hasin DS. Prescription opioid use disorder and heroin use among 12-34 year-olds in the United States from 2002 to 2014. Addict Behav. 2017 Feb;65:236-241. doi: 10.1016/j.addbeh.2016.08.033. Epub 2016 Aug 30. No abstract available.

    PMID: 27614657BACKGROUND
  • Understanding the epidemic. Retrieved from https://www.cdc.gov/drugoverdose/epidemic/index.html. Accessed 3-2-2019.2018.

    BACKGROUND
  • Forsyth CJ, Biggar RW, Chen J, Burstein K. Examining heroin use and prescription opioid misuse among adolescents. Criminal Justice Studies: A Critical Journal of Crime, Law & Society 2017;30:320-9.

    BACKGROUND
  • Sung HE, Richter L, Vaughan R, Johnson PB, Thom B. Nonmedical use of prescription opioids among teenagers in the United States: trends and correlates. J Adolesc Health. 2005 Jul;37(1):44-51. doi: 10.1016/j.jadohealth.2005.02.013.

    PMID: 15963906BACKGROUND
  • Vaughn MG, Fu Q, Perron BE, Wu LT. Risk profiles among adolescent nonmedical opioid users in the United States. Addict Behav. 2012 Aug;37(8):974-7. doi: 10.1016/j.addbeh.2012.03.015. Epub 2012 Mar 27.

    PMID: 22525786BACKGROUND
  • Wojciechowski TW. Developmental Trajectories of Opioid Use Among Juvenile Offenders: An Epidemiological Examination of Group Characteristics and Criminological Risk Factors. Subst Use Misuse. 2019;54(7):1203-1213. doi: 10.1080/10826084.2019.1573837. Epub 2019 Feb 15.

    PMID: 30767596BACKGROUND
  • Mulvey EP, Schubert CA, Chassin L. Substance Use and Offending in Serious Adolescent Offenders. In: Department of Justice OoJP, Office of Juvenile Justice and Delinquency Prevention., ed. Washington, DC: U.S. 2010.

    BACKGROUND
  • Grisso T. Double jeopardy: adolescent offenders with mental disorders. Chicago: University of Chicago Press; 2004.

    BACKGROUND
  • Ghandour LA, El Sayed DS, Martins SS. Alcohol and illegal drug use behaviors and prescription opioids use: how do nonmedical and medical users compare, and does motive to use really matter? Eur Addict Res. 2013;19(4):202-10. doi: 10.1159/000345445. Epub 2013 Feb 7.

    PMID: 23391856BACKGROUND
  • Cheng T, Small W, Nosova E, Hogg B, Hayashi K, Kerr T, DeBeck K. Nonmedical prescription opioid use and illegal drug use: initiation trajectory and related risks among people who use illegal drugs in Vancouver, Canada. BMC Res Notes. 2018 Jan 16;11(1):35. doi: 10.1186/s13104-018-3152-9.

    PMID: 29338770BACKGROUND
  • Jones CM, McCance-Katz EF. Co-occurring substance use and mental disorders among adults with opioid use disorder. Drug Alcohol Depend. 2019 Apr 1;197:78-82. doi: 10.1016/j.drugalcdep.2018.12.030. Epub 2019 Feb 14.

    PMID: 30784952BACKGROUND
  • Scott T, Brown SL. Risks, strengths, gender, and recidivism among justice-involved youth: A meta-analysis. J Consult Clin Psychol. 2018 Nov;86(11):931-945. doi: 10.1037/ccp0000343.

    PMID: 30335425BACKGROUND
  • The National Center for Addiction and Substance Abuse Research, Columbia University. Criminal Neglect: Substance Abuse, Juvenile Justice and The Children Left Behind. 2004.

    BACKGROUND
  • Mulvey EP. Highlights From Pathways to Desistance: A Longitudinal Study of Serious Adolescent Offenders. 2011.

    BACKGROUND
  • Godley SH, Smith JE, Meyers RJ, Godley MD. The Adolescent Community Reinforcement Approach: A Clinical Guide for Treating Substance Use Disorders. Normal, IL: Chestnut Health Systems; 2016.

    BACKGROUND
  • Godley SH, Meyers RJ, Smith JE, et al. The Adolescent Community Reinforcement Approach for Adolescent Cannabis Users (Cannabis Youth Treatment (Cyt) Series) - Volume 4. Rockville, MD.

    BACKGROUND
  • Ahrens KR, Dubois DL, Garrison M, Spencer R, Richardson LP, Lozano P. Qualitative exporation of relationships with important non-parental adults in the lives of youth in foster care. Child Youth Serv Rev. 2011 Jun 1;33(6):1012-1023. doi: 10.1016/j.childyouth.2011.01.006.

    PMID: 22661797BACKGROUND
  • Godley MD, Passetti LL, Subramaniam GA, Funk RR, Smith JE, Meyers RJ. Adolescent Community Reinforcement Approach implementation and treatment outcomes for youth with opioid problem use. Drug Alcohol Depend. 2017 May 1;174:9-16. doi: 10.1016/j.drugalcdep.2016.12.029. Epub 2017 Feb 22.

    PMID: 28282523BACKGROUND
  • Godley SH, Hedges K, Hunter B. Gender and racial differences in treatment process and outcome among participants in the adolescent community reinforcement approach. Psychol Addict Behav. 2011 Mar;25(1):143-54. doi: 10.1037/a0022179.

    PMID: 21443309BACKGROUND
  • Godley SH, Hunter BD, Fernandez-Artamendi S, Smith JE, Meyers RJ, Godley MD. A comparison of treatment outcomes for adolescent community reinforcement approach participants with and without co-occurring problems. J Subst Abuse Treat. 2014 Apr;46(4):463-71. doi: 10.1016/j.jsat.2013.10.013. Epub 2013 Nov 11.

    PMID: 24462478BACKGROUND
  • Henderson CE, Wevodau AL, Henderson SE, Colbourn SL, Gharagozloo L, North LW, Lotts VA. An independent replication of the Adolescent-Community Reinforcement Approach with justice-involved youth. Am J Addict. 2016 Apr;25(3):233-40. doi: 10.1111/ajad.12366. Epub 2016 Mar 18.

    PMID: 26992083BACKGROUND
  • Meyers RJ, Roozen HG, Smith JE. The community reinforcement approach: an update of the evidence. Alcohol Res Health. 2011;33(4):380-8.

    PMID: 23580022BACKGROUND
  • Fleming C, Haggerty K. Process and Outcomes Evaluation of Keys to Success. 2013.

    BACKGROUND
  • Almirall D, Nahum-Shani I, Sherwood NE, Murphy SA. Introduction to SMART designs for the development of adaptive interventions: with application to weight loss research. Transl Behav Med. 2014 Sep;4(3):260-74. doi: 10.1007/s13142-014-0265-0.

    PMID: 25264466BACKGROUND
  • Florence CS, Zhou C, Luo F, Xu L. The Economic Burden of Prescription Opioid Overdose, Abuse, and Dependence in the United States, 2013. Med Care. 2016 Oct;54(10):901-6. doi: 10.1097/MLR.0000000000000625.

    PMID: 27623005BACKGROUND
  • Pain in the nation: The drug, alcohol and suicide crises and the need for a national resilience strategy. 2017. (Accessed September 25, 2018, at http://www.paininthenation.org/assets/pdfs/TFAH-2017- PainNationRpt.pdf.)

    BACKGROUND
  • Centers for Disease Control and Prevention (CDC). CDC grand rounds: prescription drug overdoses - a U.S. epidemic. MMWR Morb Mortal Wkly Rep. 2012 Jan 13;61(1):10-3.

    PMID: 22237030BACKGROUND
  • Opioids. 2016. (at https://www.samhsa.gov/atod/opioids.)

    BACKGROUND
  • Case A, Deaton A. Mortality and morbidity in the 21st century. Brookings Pap Econ Act. 2017 Spring;2017:397-476. doi: 10.1353/eca.2017.0005.

    PMID: 29033460BACKGROUND
  • Opioid epidemic. 2016. (Accessed September 25, 2018, at https://www.atg.wa.gov/opioid-epidemic.)

    BACKGROUND
  • Schulenberg JE, Johnston LD, O'Malley PM, Bachman JG, Miech RA, Patrick ME. Monitoring the Future national survey results on drug use, 1975-2017: Volume II, College students and adults ages 19-55. Ann Arbor: Institute for Social Research, The University of Michigan; 2018.

    BACKGROUND
  • Jones CM. Heroin use and heroin use risk behaviors among nonmedical users of prescription opioid pain relievers - United States, 2002-2004 and 2008-2010. Drug Alcohol Depend. 2013 Sep 1;132(1-2):95-100. doi: 10.1016/j.drugalcdep.2013.01.007. Epub 2013 Feb 12.

    PMID: 23410617BACKGROUND
  • Banerjee G, Edelman EJ, Barry DT, Becker WC, Cerda M, Crystal S, Gaither JR, Gordon AJ, Gordon KS, Kerns RD, Martins SS, Fiellin DA, Marshall BD. Non-medical use of prescription opioids is associated with heroin initiation among US veterans: a prospective cohort study. Addiction. 2016 Nov;111(11):2021-2031. doi: 10.1111/add.13491. Epub 2016 Aug 23.

    PMID: 27552496BACKGROUND
  • Charak R, Ford JD, Modrowski CA, Kerig PK. Polyvictimization, Emotion Dysregulation, Symptoms of Posttraumatic Stress Disorder, and Behavioral Health Problems among Justice-Involved Youth: a Latent Class Analysis. J Abnorm Child Psychol. 2019 Feb;47(2):287-298. doi: 10.1007/s10802-018-0431-9.

    PMID: 29654539BACKGROUND
  • Perez NM, Jennings WG, Baglivio MT. A path to serious, violent, chronic delinquency: The harmful aftermath of adverse childhood experiences. Crime & Delinquency 2018;64:3-25.

    BACKGROUND
  • Abbott PJ. A review of the community reinforcement approach in the treatment of opioid dependence. J Psychoactive Drugs. 2009 Dec;41(4):379-85. doi: 10.1080/02791072.2009.10399776.

    PMID: 20235445BACKGROUND
  • Roozen HG, Boulogne JJ, van Tulder MW, van den Brink W, De Jong CA, Kerkhof AJ. A systematic review of the effectiveness of the community reinforcement approach in alcohol, cocaine and opioid addiction. Drug Alcohol Depend. 2004 Apr 9;74(1):1-13. doi: 10.1016/j.drugalcdep.2003.12.006.

    PMID: 15072802BACKGROUND
  • Carroll KM, Ball SA, Nich C, Martino S, Frankforter TL, Farentinos C, Kunkel LE, Mikulich-Gilbertson SK, Morgenstern J, Obert JL, Polcin D, Snead N, Woody GE; National Institute on Drug Abuse Clinical Trials Network. Motivational interviewing to improve treatment engagement and outcome in individuals seeking treatment for substance abuse: a multisite effectiveness study. Drug Alcohol Depend. 2006 Feb 28;81(3):301-12. doi: 10.1016/j.drugalcdep.2005.08.002. Epub 2005 Sep 28.

    PMID: 16169159BACKGROUND
  • Goossens I, Nicholls TL, Torchalla I, Brink J, de Ruiter C. The Perceived Impact of Trauma-Focused Research on Forensic Psychiatric Patients With Lifetime Victimization Histories. J Empir Res Hum Res Ethics. 2016 Oct;11(4):334-345. doi: 10.1177/1556264616670769. Epub 2016 Nov 25.

    PMID: 27887006BACKGROUND
  • Catalano RF, Park J, Harachi TW, Haggerty KP, Abbott RD, Hawkins JD. Mediating the effects of poverty, gender, individual characteristics, and external constraints on antisocial behavior: A test of the social development model and implications for developmental life-course theory. In: Farrington DP, ed. Advances in criminological theory: Vol 14. New Brunswick, NJ: Transaction; 2005:99-123.

    BACKGROUND
  • Catalano RF, Hawkins JD. The social development model: A theory of antisocial behavior. In: Hawkins JD, ed. Delinquency and crime: Current theories. New York: Cambridge University Press; 1996:149-97.

    BACKGROUND
  • Hirschi T. Causes of delinquency. Berkeley, CA: University of California Press; 1969.

    BACKGROUND
  • Bandura A. Social learning theory. Englewood Cliffs, NJ: Prentice Hall; 1977.

    BACKGROUND
  • Sutherland EH. Development of the theory [Private paper published posthumously]. In: Schuessler K, ed. Edwin Sutherland on analyzing crime. Chicago: University of Chicago Press; 1973:13-29.

    BACKGROUND
  • R.L. M. The current state of differential association theory. Crime and Delinquency 1988;34:277-306.

    BACKGROUND
  • Catalano RF, Gainey RR, Fleming CB, Haggerty KP, Johnson NO. An experimental intervention with families of substance abusers: one-year follow-up of the focus on families project. Addiction. 1999 Feb;94(2):241-54. doi: 10.1046/j.1360-0443.1999.9422418.x.

    PMID: 10396792BACKGROUND
  • Fleming CB, Catalano RF, Oxford ML, Harachi TW. A test of generalizability of the social development model across gender and income groups with longitudinal data from the elementary school developmental period. Journal of Quantitative Criminology 2002;18:423-39.

    BACKGROUND
  • Ford JD, Grasso DJ, Greene CA, Slivinsky M, DeViva JC. Randomized clinical trial pilot study of prolonged exposure versus present centred affect regulation therapy for PTSD and anger problems with male military combat veterans. Clin Psychol Psychother. 2018 Sep;25(5):641-649. doi: 10.1002/cpp.2194. Epub 2018 Apr 23.

    PMID: 29687524BACKGROUND
  • Ford JD, Chang R, Levine J, Zhang W. Randomized clinical trial comparing affect regulation and supportive group therapies for victimization-related PTSD with incarcerated women. Behav Ther. 2013 Jun;44(2):262-76. doi: 10.1016/j.beth.2012.10.003. Epub 2012 Nov 5.

    PMID: 23611076BACKGROUND
  • Ford JD, Grasso DJ, Hawke J, Chapman JF. Poly-victimization among juvenile justice-involved youths. Child Abuse Negl. 2013 Oct;37(10):788-800. doi: 10.1016/j.chiabu.2013.01.005. Epub 2013 Feb 19.

    PMID: 23428165BACKGROUND
  • Ford JD, Steinberg KL, Hawke J, Levine J, Zhang W. Randomized trial comparison of emotion regulation and relational psychotherapies for PTSD with girls involved in delinquency. J Clin Child Adolesc Psychol. 2012;41(1):27-37. doi: 10.1080/15374416.2012.632343.

    PMID: 22233243BACKGROUND
  • Ford JD, Steinberg KL, Zhang W. A randomized clinical trial comparing affect regulation and social problem-solving psychotherapies for mothers with victimization-related PTSD. Behav Ther. 2011 Dec;42(4):560-78. doi: 10.1016/j.beth.2010.12.005. Epub 2011 Apr 16.

    PMID: 22035986BACKGROUND
  • www.wsipp.wa.gov/BenefitCost?topicId=1 Accessed 3-2-2019.

    BACKGROUND
  • Kuklinski MR, Gibbons BJ, Bowser DM, McCollister KE, Smart R, Dunlap LJ, Shenkar E, Bonar EE, Boomer T, Campbell M, Fiellin LE, Hutton DW, Rao V, Saldana L, Su K, Walton MA, Yilmazer T. Investing in Interventions to Prevent Opioid Use Disorder in Adolescents and Young Adults: Start-up Costs from NIDA's HEAL Prevention Initiative. Prev Sci. 2025 Nov;26(7):1045-1055. doi: 10.1007/s11121-025-01835-6. Epub 2025 Oct 14.

  • Brincks AM, Haggerty KP, Kolberg A, Albertson KM, McCarty CA, Kuklinski MR, Ryle T, Ahrens KR. Development of the Positive Outcomes through Supported Transition (POST) opioid preventive intervention for youth in the legal system: Study protocol for a sequential multiple assignment randomized trial. Contemp Clin Trials. 2025 Feb;149:107782. doi: 10.1016/j.cct.2024.107782. Epub 2024 Dec 18.

  • Ahrens KR, Brincks AM, Haggerty KP, McCarty CA, Dean S, Albertson KM, Cross SR, Ryle T, Wun A. Designing and piloting a sequential multiple assignment randomized trial for opioid prevention among youth in the legal system. Psychol Addict Behav. 2025 Feb;39(1):14-26. doi: 10.1037/adb0001025. Epub 2024 Sep 9.

  • Ahrens K, Blackburn N, Aalsma M, Haggerty K, Kelleher K, Knight DK, Joseph E, Mulford C, Ryle T, Tolou-Shams M. Prevention of Opioid Use and Disorder Among Youth Involved in the Legal System: Innovation and Implementation of Four Studies Funded by the NIDA HEAL Initiative. Prev Sci. 2023 Oct;24(Suppl 1):99-110. doi: 10.1007/s11121-023-01566-6. Epub 2023 Jul 1.

Related Links

MeSH Terms

Conditions

Substance-Related DisordersRecidivismOpioid-Related Disorders

Interventions

Educational StatusTherapeuticsMotivational Interviewing

Condition Hierarchy (Ancestors)

Chemically-Induced DisordersMental DisordersCriminal BehaviorBehaviorNarcotic-Related Disorders

Intervention Hierarchy (Ancestors)

Socioeconomic FactorsPopulation CharacteristicsDirective CounselingCounselingMental Health ServicesBehavioral Disciplines and ActivitiesHealth ServicesHealth Care Facilities Workforce and Services

Study Officials

  • Kym Ahrens, MD MPH

    Seattle Children's Hospital

    PRINCIPAL INVESTIGATOR
  • Kevin Haggerty, MSW PhD

    University of Washington

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Masking Details
The Outcomes Assessor (data collection team) will not be aware of the participant's study arm when they collect survey data.
Purpose
PREVENTION
Intervention Model
SEQUENTIAL
Model Details: Sequential Multiple Assignment Randomized Trial
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Professor, Division of Adolescent Medicine

Study Record Dates

First Submitted

February 11, 2021

First Posted

May 25, 2021

Study Start

January 20, 2021

Primary Completion

August 31, 2024

Study Completion

August 31, 2024

Last Updated

October 27, 2022

Record last verified: 2022-10

Data Sharing

IPD Sharing
Will share

Individual participant data will be shared with other researchers in the HEAL Prevention Collaborative. Further specific detail will be reported as the plans are finalized.

Shared Documents
STUDY PROTOCOL, CSR, ANALYTIC CODE
Time Frame
Within four weeks of acceptance by a journal, we will deposit electronic copies of publications in PubMed Central. Publications will be made publicly available immediately without any embargo period.

Locations